1062-P: Insulin Requirement Profiles of Short-Term Continuous Subcutaneous Insulin Infusion Therapy in Chinese Patients with Type 2 Diabetic Nephropathy

Diabetes ◽

10.2337/db19-1062-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1062-P

Author(s):

SHUO LIN ◽

KUIXING ZHANG ◽

PING LI ◽

KE FANG ◽

LONGYI ZENG

Keyword(s):

Diabetic Nephropathy ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Insulin Requirement ◽

Chinese Patients ◽

Infusion Therapy ◽

Subcutaneous Insulin ◽

Type 2 Diabetic

Download Full-text

Insulin Requirement Profiles of Patients with Type 2 Diabetes After Achieving Stabilized Glycemic Control with Short-Term Continuous Subcutaneous Insulin Infusion

Diabetes Technology & Therapeutics ◽

10.1089/dia.2009.0131 ◽

2010 ◽

Vol 12 (4) ◽

pp. 271-281 ◽

Author(s):

Yun-Hee Noh ◽

Won-Jin Lee ◽

Kyoung-Ah Kim ◽

Inja Lim ◽

Jun-Ho Lee ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Insulin Requirement ◽

Subcutaneous Insulin ◽

Download Full-text

Abstract #162: Dramatic Reduction in Insulin Requirement after Starting Continuous Subcutaneous Insulin Infusion Using U500 Insulin in a Patient With Type 2 Diabetes and Severe Insulin Resistance

Endocrine Practice ◽

10.1016/s1530-891x(20)43960-6 ◽

2006 ◽

Vol 12 ◽

pp. 10

Author(s):

Thottathil Gopan ◽

Elias Siraj

Keyword(s):

Insulin Resistance ◽

Type 2 Diabetes ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Insulin Requirement ◽

Dramatic Reduction ◽

Subcutaneous Insulin ◽

Severe Insulin Resistance

Download Full-text

Short-Term Effects of Continuous Subcutaneous Insulin Infusion Therapy in Perioperative Patients with Diabetes Mellitus

Diabetes Technology & Therapeutics ◽

10.1089/dia.2013.0117 ◽

2013 ◽

Vol 15 (12) ◽

pp. 1010-1018 ◽

Author(s):

Delin Ma ◽

Cai Chen ◽

Yu Lu ◽

Jingdong Ma ◽

Ping Yin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Infusion Therapy ◽

Subcutaneous Insulin ◽

Patients With Diabetes ◽

Short Term Effects

Download Full-text

Factors associated with improved glycemic control following continuous subcutaneous insulin infusion therapy in patients with type 2 diabetes uncontrolled with bolus-basal insulin regimens: An analysis from the OpT2mise randomized trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12960 ◽

2017 ◽

Vol 19 (10) ◽

pp. 1490-1494 ◽

Author(s):

Muriel Metzger ◽

Javier Castañeda ◽

Yves Reznik ◽

Francesco Giorgino ◽

Ignacio Conget ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Randomized Trial ◽

Basal Insulin ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Infusion Therapy ◽

Subcutaneous Insulin ◽

Factors Associated

Download Full-text

Continuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia

Journal of Evaluation in Clinical Practice ◽

10.1111/j.1365-2753.2009.01134.x ◽

2010 ◽

Vol 16 (1) ◽

pp. 202-205 ◽

Author(s):

I-Te Lee ◽

Yi-Ju Liau ◽

Wen-Jane Lee ◽

Chien-Ning Huang ◽

Wayne H-H. Sheu

Keyword(s):

Quality Of Life ◽

Glycemic Control ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Subcutaneous Insulin ◽

Type 2 Diabetic

Download Full-text

Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy

Diabetes/Metabolism Research and Reviews ◽

10.1002/dmrr.343 ◽

2003 ◽

Vol 19 (2) ◽

pp. 124-130 ◽

Author(s):

Sunmin Park ◽

Soo Bong Choi

Keyword(s):

Type 2 Diabetes ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Infusion Therapy ◽

Subcutaneous Insulin ◽

Korean Type ◽

Diabetes Patients

Download Full-text

Short-Term Continuous Subcutaneous Insulin Infusion Combined with Insulin Sensitizers Rosiglitazone, Metformin, or Antioxidant α-Lipoic Acid in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Diabetes Technology & Therapeutics ◽

10.1089/dia.2013.0013 ◽

2013 ◽

Vol 15 (10) ◽

pp. 859-869 ◽

Author(s):

Zhimin Huang ◽

Xuesi Wan ◽

Juan Liu ◽

Wanping Deng ◽

Ailing Chen ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Subcutaneous Insulin ◽

Newly Diagnosed ◽

Insulin Sensitizers

Download Full-text

Abstract #805134: Effect of FIASP on Glycaemic Targets in Type 2 Diabetic Subjects, When Used in the Medtronic Minimed 640G Continuous Subcutaneous Insulin Infusion (CSII) Pump

Endocrine Practice ◽

10.1016/s1530-891x(20)39609-9 ◽

2020 ◽

Vol 26 ◽

pp. 116-117

Author(s):

Brijendra Srivastava

Keyword(s):

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Subcutaneous Insulin ◽

Type 2 Diabetic

Download Full-text

Comparing the Efficacy and Safety Between Short-term Continuous Subcutaneous Beinaglutide Injection and Continuous Subcutaneous Insulin Infusion (CSII) for Newly Diagnosed Type 2 Diabetes

Case Medical Research ◽

10.31525/ct1-nct03987308 ◽

2019 ◽

Author(s):

Keyword(s):

Type 2 Diabetes ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Subcutaneous Insulin ◽

Newly Diagnosed ◽

Efficacy And Safety ◽

Download Full-text

Treatment with intravenous insulin followed by continuous subcutaneous insulin infusion improves glycaemic control in severely resistant Type 2 diabetic patients

Diabetic Medicine ◽

10.1046/j.1464-5491.2003.00848.x ◽

2003 ◽

Vol 20 (1) ◽

pp. 76-79 ◽

Author(s):

M.-J. J. Pouwels ◽

C. J. Tack ◽

A. R. Hermus ◽

J. A. Lutterman

Keyword(s):

Glycaemic Control ◽

Continuous Subcutaneous Insulin Infusion ◽

Insulin Infusion ◽

Diabetic Patients ◽

Subcutaneous Insulin ◽

Type 2 Diabetic Patients ◽

Intravenous Insulin ◽

Type 2 Diabetic

Download Full-text